EUVIMEDEUVIMED entdecken
Crossref

Chelidonic Acid Monohydrate Attenuates Isoproterenol-Induced Myocardial Infarction via Modulation of Nuclear Factor Erythroid 2-Related Factor 2/Nuclear Factor Kappa B–Mediated Oxidative Stress and Inflammation

Maya Jangid, Muqtada Shaikh, Akshata Pahelkar, Janavie Patel, Gaurav Doshi iD

Drug Research · 10.11.2026

DOI: 10.1055/a-2987-5776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, online erschienen am 10.11.2026. Verfasst von Maya Jangid und 4 weiteren Autor:innen. Beteiligte Einrichtung: SVKM's Dr Bhanuben Nanavati College of Pharmacy, Pharmacology, India, Mumbai. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to assess the cardioprotective activity of chelidonic acid monohydrate in an isoproterenol-induced myocardial infarction model in rats. Chelidonic acid monohydrate was administered orally at doses of 5, 10, and 20 mg/kg for 7 days, and its effects were evaluated using hemodynamic, electrocardiographic, morphometric, biochemical, and histopathological parameters. Chelidonic acid monohydrate demonstrated significant cardioprotective activity at doses of 10 and 20 mg/kg, as evidenced by improvements in hemodynamic and biochemical parameters, along with attenuation of structural changes such as cardiac hypertrophy and the normalization of electrocardiographic patterns. Treatment with chelidonic acid monohydrate also significantly reduced myocardial injury and fibrosis. Furthermore, chelidonic acid monohydrate modulated oxidative stress and inflammatory pathways as indicated by increased levels of antioxidant enzymes (superoxide dismutase and catalase) and decreased levels of pro-inflammatory mediators (nuclear factor kappa B, tumor necrosis factor-alpha, and interleukin-6). Molecular docking studies confirmed strong binding affinities of chelidonic acid monohydrate to key myocardial infarction–related targets, including nuclear factor erythroid 2–related factor 2, nuclear factor kappa B, tumor necrosis factor-alpha, and interleukin-6, with binding free energy values of−7.84,−7.59,−6.12, and−6.41 kcal/mol, respectively. Overall, these findings suggest that the cardioprotective effects of chelidonic acid monohydrate are mediated through modulation of the nuclear factor erythroid 2–related factor 2/nuclear factor kappa B pathway. This study provides compelling evidence supporting chelidonic acid monohydrate as a potential therapeutic agent for myocardial infarction, warranting further studies to assess its long-term efficacy.

Autor:innen und Institutionen

  • SVKM's Dr Bhanuben Nanavati College of Pharmacy, Pharmacology, India, Mumbai.
  • SVKM's Dr Bhanuben Nanavati College of Pharmacy, Pharmaceutical Analysis, MH, India, Mumbai.

ORCID-Profile: Gaurav Doshi

Zitieren

APA

Jangid, M., Shaikh, M., Pahelkar, A., Patel, J., & Doshi, G. (2026). Chelidonic Acid Monohydrate Attenuates Isoproterenol-Induced Myocardial Infarction via Modulation of Nuclear Factor Erythroid 2-Related Factor 2/Nuclear Factor Kappa B–Mediated Oxidative Stress and Inflammation. Drug Research. https://doi.org/10.1055/a-2987-5776

Vancouver

Jangid M, Shaikh M, Pahelkar A, Patel J, Doshi G. Chelidonic Acid Monohydrate Attenuates Isoproterenol-Induced Myocardial Infarction via Modulation of Nuclear Factor Erythroid 2-Related Factor 2/Nuclear Factor Kappa B–Mediated Oxidative Stress and Inflammation. Drug Research. 2026. doi:10.1055/a-2987-5776

BibTeX
@article{Jangid2026,
  author = {Jangid, Maya and Shaikh, Muqtada and Pahelkar, Akshata and Patel, Janavie and Doshi, Gaurav},
  title = {Chelidonic Acid Monohydrate Attenuates Isoproterenol-Induced Myocardial Infarction via Modulation of Nuclear Factor Erythroid 2-Related Factor 2/Nuclear Factor Kappa B–Mediated Oxidative Stress and Inflammation},
  journal = {Drug Research},
  year = {2026},
  doi = {10.1055/a-2987-5776}
}
Kostenlos starten →